InvestorsHub Logo
Followers 46
Posts 2450
Boards Moderated 0
Alias Born 04/17/2019

Re: B52T38 post# 75121

Wednesday, 05/06/2020 7:17:00 AM

Wednesday, May 06, 2020 7:17:00 AM

Post# of 232307

What is your opinion of Adam Feuerstein?



He is often right. But in small biopharmacy stocks, going negative is like shooting fish in a barrel. Most drugs and biopharmaceutical companies fail and of those that don't finances, small patients populations or other problems bedevil most of the others. He spouts off having done little to no due diligence which is why when he's wrong, he's spectacularly wrong.

Also having mentored under Jim Cramer who has gone negative on stocks he's shorted and looking like he's using Jim's playbook, I wouldn't trust a single opinion of his.

Cytodyn is one of his spectacular failures. Financing might be seat of the pants but can be overcome. Leronlimab itself is a grand slam with more revenue potential than any drug current;y in existence.

With CTSO, Cytodyn will claim part of it's market but do less damage then it will to big pharmaceutical companies.

ps. Adam Feuerstein is also a general all around douchebag.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News